Nina Kjellson, Director at Cidara Therapeutics, holds 4.18M shares in Tyra Bioscience (Ticker: TYRA), holds 0.00 shares in Ocera Therapeutics (Ticker: OCRX), holds 1.60M shares in Eiger Biopharmaceuticals (Ticker: EIGRQ). Most recently, Nina Kjellson Sold ― shares of Tyra Bioscience on Nov 26, 2024 for an estimated value of 88.73K.
Nina Kjellson latest transaction was an Informative Sell of $88.73K.
What was Nina Kjellson's most profitable transaction?
Nina Kjellson’s most profitable transaction was an Informative Sell of TYRA stock on November 6, 2024. The return on the trade was 18.20%.
What is Nina Kjellson's role in Cidara Therapeutics?
Nina Kjellson's role in Cidara Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.